NVDA
57
-2
K
44
6
MMM
52
2
MDLZ
32
8
WU
16
2
EMR
51
-3
MHK
42
2
LOW
30
-9
MAR
59
2
MSFT
64
-3
FITB
59
3
EXPD
35
3
CHD
24
-11
T
59
2
NKE
25
-3
WM
60
-4
RL
70
-3
MDT
59
2
ZTS
19
3
AKAM
40
-2
NVDA
57
-2
K
44
6
MMM
52
2
MDLZ
32
8
WU
16
2
EMR
51
-3
MHK
42
2
LOW
30
-9
MAR
59
2
MSFT
64
-3
FITB
59
3
EXPD
35
3
CHD
24
-11
T
59
2
NKE
25
-3
WM
60
-4
RL
70
-3
MDT
59
2
ZTS
19
3
AKAM
40
-2
Financhill
Back

Allegiant Travel Vs. Apellis Pharmaceuticals Industry Stock Comparison

Sell
15

ALGT
Allegiant Travel

Last Price:
$50.19
Seasonality Move:
-0.11%
Sell
34

APLS
Apellis Pharmaceuticals

Last Price:
$17.70
Seasonality Move:
-9.52%
Sell
15
Allegiant Travel (ALGT) is a Sell

Is Allegiant Travel a Buy, Sell or Hold?

  • The current Allegiant Travel [ALGT] share price is $50.22. The Score for ALGT is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
  • ALGT is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
34
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $17.69. The Score for APLS is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ALGT Stock Price Chart

What is Allegiant Travel's stock price today?

  • The Allegiant Travel share price today is $50.22
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALGT is experiencing selling pressure, which indicates risk of future bearish movement.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $17.69
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

ALGT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.44 Sell
Relative Strength Index (14 RSI): 41.91 Sell
Chaikin Money Flow: -264754 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (52.47 - 56.89) Sell
Bollinger Bands (100): (44.49 - 78.59) Sell

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.08 Sell
Relative Strength Index (14 RSI): 42.98 Sell
Chaikin Money Flow: -561522 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (17.2 - 19.06) Sell
Bollinger Bands (100): (17.72 - 26.54) Sell

ALGT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 53.15 Sell
20-day SMA: 54.68 Sell
50-day SMA: 51.62 Sell
200-day SMA: 65.84 Sell
8-day EMA: 52.7 Sell
20-day EMA: 53.78 Sell
50-day EMA: 54.82 Sell
200-day EMA: 62.81 Sell

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 18.56 Sell
20-day SMA: 18.3 Sell
50-day SMA: 18.27 Sell
200-day SMA: 26.83 Sell
8-day EMA: 18.25 Sell
20-day EMA: 18.36 Sell
50-day EMA: 19.23 Sell
200-day EMA: 26.97 Sell

Allegiant Travel Earnings Growth & ALGT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.79 per share, an increase next quarter of $3.00 per share, an increase this year of $0.96 per share, and an increase next year of $3.15 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.11 per share, an increase next quarter of $0.18 per share, a decrease this year of $0.14 per share, and an increase next year of $1.12 per share.

Allegiant Travel Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):